BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36635241)

  • 21. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of m
    Jiang L; Roberts R; Wong M; Zhang L; Webber CJ; Kilci A; Jenkins M; Sun G; Rashad S; Sun J; Dedon PC; Daley SA; Xia W; Ortiz AR; Dorrian L; Saito T; Saido TC; Wolozin B
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
    Nies SH; Takahashi H; Herber CS; Huttner A; Chase A; Strittmatter SM
    J Biol Chem; 2021 Oct; 297(4):101159. PubMed ID: 34480901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of m
    Jiang L; Roberts R; Wong M; Zhang L; Webber CJ; Kilci A; Jenkins M; Sun J; Sun G; Rashad S; Dedon PC; Daley SA; Xia W; Ortiz AR; Dorrian L; Saito T; Saido TC; Wolozin B
    Res Sq; 2023 May; ():. PubMed ID: 37292629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice.
    Yan XX; Cai Y; Shelton J; Deng SH; Luo XG; Oddo S; Laferla FM; Cai H; Rose GM; Patrylo PR
    PLoS One; 2012; 7(11):e48782. PubMed ID: 23155407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-Dependent Sex Differences in Perineuronal Nets in an
    Rahmani R; Rambarack N; Singh J; Constanti A; Ali AB
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
    Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H
    J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice.
    Barendrecht S; Schreurs A; Geissler S; Sabanov V; Ilse V; Rieckmann V; Eichentopf R; Künemund A; Hietel B; Wussow S; Hoffmann K; Körber-Ferl K; Pandey R; Carter GW; Demuth HU; Holzer M; Roßner S; Schilling S; Preuss C; Balschun D; Cynis H
    Alzheimers Res Ther; 2023 Jan; 15(1):16. PubMed ID: 36641439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APP
    Mehla J; Lacoursiere SG; Lapointe V; McNaughton BL; Sutherland RJ; McDonald RJ; Mohajerani MH
    Neurobiol Aging; 2019 Mar; 75():25-37. PubMed ID: 30508733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
    Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
    Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.
    Mowry FE; Espejo-Porras F; Jin S; Quadri Z; Wu L; Bertolio M; Jarvis R; Reynolds C; Alananzeh R; Bieberich E; Yang Y
    Neurobiol Dis; 2023 Aug; 184():106213. PubMed ID: 37364689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (S)-[
    Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
    Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App
    Andersson E; Schultz N; Saito T; Saido TC; Blennow K; Gouras GK; Zetterberg H; Hansson O
    Alzheimers Res Ther; 2023 Mar; 15(1):64. PubMed ID: 36964585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
    Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
    Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
    Jiang R; Smailovic U; Haytural H; Tijms BM; Li H; Haret RM; Shevchenko G; Chen G; Abelein A; Gobom J; Frykman S; Sekiguchi M; Fujioka R; Watamura N; Sasaguri H; Nyström S; Hammarström P; Saido TC; Jelic V; Syvänen S; Zetterberg H; Winblad B; Bergquist J; Visser PJ; Nilsson P
    Acta Neuropathol Commun; 2022 Jul; 10(1):96. PubMed ID: 35787306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.